Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Detection, characterisation and targeting of minimal residual disease

MRD and adjuvant clinical trial design

Date

12 Sep 2022

Session

Detection, characterisation and targeting of minimal residual disease

Topics

Translational Research

Tumour Site

Presenters

Sarah-Jane Dawson

Authors

S. Dawson

Author affiliations

  • Level 12 Research Department, Peter MacCallum Cancer Centre, 3000 - Melbourne/AU

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Conclusions and perspectives 

Presenter: Katerina Politi

Session: Detection, characterisation and targeting of minimal residual disease

Resources:

Webcast

Discussion

Presenter: All Speakers

Session: Detection, characterisation and targeting of minimal residual disease

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.